Mepolizumab Edges Out Dupilumab in Head-to-Head Real-World Asthma Biologic Showdown Among Older Medicare Patients
A large real-world study of Medicare beneficiaries found mepolizumab matched dupilumab for preventing asthma hospitalizations and significantly reduced exacerbation rates, ...
